Inhibition of cMYC-MAX transcription factors hetero-dimerization with structurally engineered omoMYC to downregulate oncogenic pathways in renal carcinoma. - Wenfeng Li; Farah Bano; Abbas Khan; Dong-Qing Wei; Abdulrahman Alshammari; Bin Xu; Yanjing Wang 003 (Comput. Biol. Medicine, 2023)